Status Awaiting development
Technology type Medicine
Decision Awaiting decision
Process TA
ID number 11810

Project Team

Project lead

Email enquiries


Key events during the development of the guidance:

Date Update
27 January 2023 For information, the company have advised that they are no longer pursuing a Marketing Authorisation Application from the Medicines and Healthcare products Regulatory Agency for this indication at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme. NICE will continue to monitor any development and will update interested parties if the situation changes.
23 November 2022 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on our processes and methods, please see our CHTE processes and methods manual